A randomized controlled trial comparing the efficacy of controlled-release oxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets (5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin
2001 ◽
Vol 85
(7)
◽
pp. 793-798
◽
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 13
(3)
◽
pp. 268-275
◽
Keyword(s):
2007 ◽
Vol 39
(10)
◽
pp. 896-901
◽
2014 ◽
Vol 76
◽
pp. 120-125
◽
Keyword(s):
2006 ◽
Vol 117
(4)
◽
pp. 802-809
◽